Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Achuta K. Guddati"'
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 725-728 (2020)
Osteosarcoma of the skull has poor outcomes. This case report describes the presentation and clinical course of a patient who was diagnosed with osteosarcoma of the skull involving the cribriform plate. After her initial diagnosis, she developed esot
Externí odkaz:
https://doaj.org/article/ea32dec49d094834890ccb37cf0e55c4
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 754-759 (2020)
Patients with novel corona virus infection (COVID-19) can develop acute respiratory failure secondary to acute respiratory distress syndrome. Cytokine storm is suggested as one of underlying mechanisms for the rapid clinical decline. Immunocompromise
Externí odkaz:
https://doaj.org/article/28a8210796884fdb83bef382ff01fe81
Autor:
Pavan Annamaraju, Swathi Gopishetty, Naga Goparaju, Matthew Beasey, Vamsi Kota, Achuta K. Guddati
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 583-587 (2020)
Enasidenib is an FDA-approved isocitrate dehydrogenase 2 (IDH2) inhibitor, which is used in the treatment of acute myeloid leukemia (AML). We present a case of AML with an IDH2 mutation treated with a regimen of enasidenib and 5-azacitidine, where th
Externí odkaz:
https://doaj.org/article/a98464ff85ad428ea0c90ef86216f711
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 534-537 (2020)
Chronic myelogenous leukemia (CML) is a hematopoietic disorder caused by the BCR/ABL gene or Philadelphia chromosome. The first Food and Drug Administration (FDA)-approved tyrosine kinase inhibitor for treatment of CML was imatinib in 2001. Since the
Externí odkaz:
https://doaj.org/article/c9e85d8d727d45db9753bbe96a56efed
Publikováno v:
Case Reports in Oncological Medicine, Vol 2020 (2020)
Ruxolitinib has become a new therapeutic option for steroid refractory graft-versus-host disease (srGVHD), with a substantial remission rate. Its anti-inflammatory properties by blocking interleukin pathways have made it a novel therapeutic approach
Externí odkaz:
https://doaj.org/article/c5bbcba8d9d945fcb3de66725250c624
Publikováno v:
Case Reports in Oncology, Vol 7, Iss 1, Pp 182-187 (2014)
Adrenal myelolipomas are rare benign tumors of the adrenal cortex composed of adipose and hematopoietic cells. They have been postulated to arise from repeated stimulation by stress, inflammation and ACTH oversecretion. Myelolipomas are usually detec
Externí odkaz:
https://doaj.org/article/806a32ca95e64d479f887d5980d7e4e6
Autor:
Shagufta Shaheen, Achuta K. Guddati
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 1, Pp 148-153 (2013)
Gastrointestinal stromal tumors (GISTs) are rare abdominal tumors which arise from the interstitial cells of Cajal in the gastrointestinal tract. Gastric GISTs are the most commonly seen GIST tumors and may grow to a very large size. They are often a
Externí odkaz:
https://doaj.org/article/32a112bac0c94d03b39a9d8f2e149c86
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 1, Pp 114-118 (2013)
Primary effusion lymphoma (PEL) is a subset of large B cell lymphomas and has been mostly associated with human immunodeficiency virus infection. Rare cases have been reported in organ transplant recipients and chronic hepatitis C patients. It typica
Externí odkaz:
https://doaj.org/article/5f2a2302d5b144b892f3bb7ea764a892
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 1, Pp 119-126 (2013)
Uterine leiomyosarcoma is a rare malignancy and carries a poorer prognosis when compared to endometrial carcinoma. It has been observed to metastasize to all the major organs. It presents with symptoms of abdominal distension, vaginal bleeding and ma
Externí odkaz:
https://doaj.org/article/0c03a5dd4ac24dca821d4f15f42a6780
Autor:
Achuta K. Guddati, Creticus P. Marak
Publikováno v:
Case Reports in Oncology, Vol 5, Iss 2, Pp 246-252 (2012)
Renal cell carcinoma is an aggressive disease with a high rate of mortality. It is known to metastasize to the lung, liver, bone and brain. However, manifestation through lymphatic spread to the lungs is rare. Lymphangitic carcinomatosis is commonly
Externí odkaz:
https://doaj.org/article/5078e121b7c742dfabcabfa425e6957a